Robotic Surgery Lobectomy

More in this section:

Robotic surgery lobectomy represents a cutting-edge approach for the surgical removal of primary malignant lesions, metastatic lesions and benign lesions of the peripheral and central lung. The first robot-assisted right lower-lobe excisional biopsy procedure in the region was performed at Lutheran Hospital Nov. 12, 2010.

Use of robotic surgery allows formal, anatomical resection, along with complete mediastinal lymph node dissection—the gold standard treatment for early-stage nonsmall cell lung cancer. This approach provides effective treatment without the need for formal thoracotomy (open technique) or facilitation-access mini-thoracotomy (video-assisted thoracic sugary or WATS technique).

Potential patient benefits include:

  • No access thoracotomy/no rib spreading
  • Reduced cancer reoccurrence, mortality in advanced disease
  • Reduced pain, postoperative neuralgia
  • Less blood loss
  • Fewer complications

Highlights of the lobectomy procedure include a totally endoscopic approach using single intercostal port placement and advanced dexterity, provided by instrumentation that enables access and exposure to upper, middle and lower lobes. This allows performance of a complete anatomical resection with specimen retrieval—without the need for rib spreading. 3DHD vision and advanced instrumentation also provides improved accuracy of dissection, limiting blood loss and enabling precise isolation of vascular structure.

Before you decide on surgery, discuss treatment options with your doctor. Understanding the risks and benefits of each treatment can help you determine the best option for you.